Rare Disease Biotech Offers Access Ahead of Key Milestone
This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.
| Open | 350.86 | Prev Close | 352.33 |
| High | 358.54 | Low | 344.40 |
| Volume | 10,551,955 | Volume (Avg) | 11,543 |
| 52 Week High | 543.00 | 52 Week Low | 178.00 |
| Market Cap | 99.8B | PE Ratio | 30.97 |
General
| Name | Strategy Inc |
| Ticker | MSTR |
| Exchange | NASDAQ |
| Sector | Technology |
| Industry | Software - Application |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 1,512 |
About Strategy Inc
Strategy Inc, together with its subsidiaries, operates as a bitcoin treasury company in the United States, Europe, the Middle East, Africa, and internationally. The company offers investors varying degrees of economic exposure to Bitcoin by offering a range of securities, including equity and fixed income instruments. It also provides AI-powered enterprise analytics software, including Strategy One, which provides non-technical users with the ability to directly access novel and actionable insights for decision-making; and Strategy Mosaic, a universal intelligence layer that offers enterprises with consistent definitions and governance across data sources, regardless of where that data resides or which tools access it. The company was formerly known as MicroStrategy Incorporated and changed its name to Strategy Inc in August 2025. The company was incorporated in 1989 and is headquartered in Tysons Corner, Virginia.
Highlights
| Analyst Target | 562.69 |
| Market Cap | 99,767,200,000 |
| PE Ratio | 30.97 |
| PEG Ratio | 3.09 |
| EBITDA | 6,676,076,032 |
Valuation
| Trailing PE | 24.72 |
| Forward PE | 10.49 |
| Price/Sales (Trailing 12 Mt.) | 216.27 |
| Price/Book (Most Recent Quarter) | 2.02 |
Technicals
| Beta | 3.90 |
| 52 Week High | 543 |
| 52 Week Low | 178 |
| 50 Day Average | -0.27% |
| 200 Day Average | 0.23% |
Earnings
MP Materials Tops List For Rare Earth Exposure, Says Analyst
Rare earth stocks are gaining attention as demand for magnets in EVs, robotics, and advanced air mobility is set to double by 2035.
Tesla Set To Hit $3 Trillion in 2026—Dan Ives
Tesla bull and Wedbush tech analyst Dan Ives sees Tesla reaching a $1 trillion valuation before the end of 2026.
Crypto Meets Wall Street - Are You Ready? - Ad
The Hedge Fund Summit is bringing top minds from crypto and traditional finance together. Discover new strategies, insights, and connections that could shape your portfolio's future.
Web of business interests shows that Kimmel's future rests on far more than his jokes
NEW YORK (AP) — The decision about whether to keep on his late-night ABC show depends on far more than his jokes. The choice is complicated by a web of business and regulatory considerations involving ABC’s parent company, other media companies and the Trump administration.
Trump And Musk Reunite, Nuclear Stocks Soar, Kimmel's Comeback Breaks Records And More: This Week In Politics
It’s been an eventful week with significant developments in the world of politics and late-night television.
Nvidia Is About to Shock the World: October 23rd - Ad
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: October 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.
Ex-Trump Lawyer Raises Alarms: 'I Have Never Been As Concerned As To Whether Our System Can Withstand The Pressure'
Abbe Lowell, a lawyer who once represented President Donald Trump's family, has expressed grave concerns over the potential harm the current administration could cause to the country's institutions.
Cathie Wood's Reshuffle Tuesday: Loads Up On AMD, Figma And Bullish, Trims Tempus AI
On Tuesday, Cathie Wood-led Ark Invest executed significant trades, including buying shares of Advanced Micro Devices Inc. (NASDAQ:AMD) and Bullish Inc. (NYSE:BLSH), while selling shares o
New Biotech Offering Targets $426B Rare Disease Market - Ad
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
Lockheed Martin Counters Boeing's F-47 Victory With Cost-Effective F-35 Upgrade Using Sixth-Gen Technology
Lockheed Martin is countering Boeing's F-47 win with a cost-effective F-35 upgrade that integrates sixth-generation tech, aiming to offer 80% of the F-47's capabilities at half the price.
New York City's Wealthiest Neighborhoods Witness 60% Rent Surge Since Pandemic
House rental rates in some of the wealthiest neighborhoods of New York City have surged by over 60% since the COVID-19 pandemic began, putting even high-income earners in a tight spot.
[Revealed] Trump's Next AI Executive Orders? - Ad
A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.
BlackRock Turns Popular Mutual Funds Into Global Equity ETFs
BlackRock turns two top mutual funds into active ETFs, giving investors global equity exposure and strategies to manage volatility.
Warner Bros, Oracle, And Micron Technology Are Among The Top 10 Large-Cap Gainers Last Week (Sep. 8 - Sep. 12): Are The Others In Your Portfolio?
Deal buzz, analyst upgrades, and AI momentum drove top weekly gainers—led by Warner Bros., Oracle, and Micron—across large-cap tech and media.
The "Mar-A-Lago Accord" Is Now Underway - Ad
The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)
Big Tech's energy-hungry data centers could be bumped off grids during power emergencies
HARRISBURG, Pa. (AP) — With the explosive growth of Big Tech's data centers threatening to overload U.S. electricity grids, policymakers are taking a hard look at a tough-love solution: bumping the energy-hungry data centers off grids during power emergencies.
Elon Musk Back Atop Billionaires List, Tesla CEO Almost Recovers Lost Wealth Since Joining Hands With Trump
Elon Musk almost recovers wealth lost since aligning with Trump for 2024 election; now richest person thanks to surging Tesla stocks.
Time to Say Goodbye to "Old" Dollar? Say Hello to "Trump's New Dollar" - Ad
If you have any money in U.S. dollars... learn how to prepare for "Trump's new dollar"... Because this could be the biggest change to our financial system in 54 years. President Trump even called it: "The greatest revolution in financial technology since the birth of the internet itself."
Supermicro Unveils New AI Servers In Madrid As Nvidia Partnership Deepens
Super Micro Computer (SMCI) unveils new AI-optimized servers at its INNOVATE! event in Madrid, featuring Nvidia's latest GPUs.
US jobless aid applications retreat to 231,000 after surging to nearly 4-year high a week earlier
The number of Americans applying for jobless aid last week retreated significantly after surging to a nearly four-year high a week earlier.
Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad
A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.
Charlie Kirk Raised $85 Million Last Year — Widow Vows to Continue His Work
The assassination of Turning Point USA founder Charlie Kirk at a Utah Valley University event on September 10 has cast a shadow of uncertainty over the future of his political and business ventures.
Here's Novo Nordisk's First Oral Obesity Drug In Europe With Proven Heart Health Impact
EMA approved Rybelsus' label update after the SOUL trial showed it cuts heart attack, stroke, and death by 14% in high-risk type 2 diabetes patients.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
Apple's iPhone 17 Series Takes Off, Meta's New Smart Glasses And Major Partnerships In AI Space: This Week In AI
This weekend's tech roundup featured Apple's strong iPhone 17 launch in China and India, Meta's new smart glasses, major AI partnerships like Intel-Nvidia and PayPal-Google, and Jim Cramer questioning Huawei's chip breakthrough.
US Investors Cling To Record $7.7 Trillion In Money-Market Funds Amid Rate Cuts
US investors are steadfastly holding a record $7.7 trillion in money-market funds, with no immediate intentions of shifting the funds elsewhere.
Elon's $25 Trillion Confession - Ad
Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.
AI Bull Market Fuels A Wave Of New Listings: 3 IPO ETFs In Focus
IPO-ETFs like IPO, FPX and FPXI are in focus as the U.S. market sees its fastest rebound since 2021, fueled by the AI boom and $23B raised year-to-date.
FDA takes aim at Hims and other telehealth services in drug advertising blitz
WASHINGTON (AP) — For the first time, federal health officials are taking aim at promoting unofficial versions of prescription drugs — including popular weight loss medications — as part of the on pharmaceutical advertising.
Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad
This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.
Co-Diagnostics Stock Plunges 28% In Pre-Market Despite Strategic Saudi Partnership
Co-Diagnostics (CODX) shares dropped 24.87% in pre-market trading after an 80.76% surge, despite announcing a strategic partnership.
Elizabeth Warren, Jack Reed Warn SEC Against 'Significant Mistake' Of Curbing Shareholder Lawsuits Against Companies: Report
Sen. Elizabeth Warren (D-Mass) and other democrats have issued a stern warning to the Securities and Exchange Commission (SEC) against any potential policy change that could limit shareholders' ability to sue companies.
Crypto Meets Wall Street - Are You Ready? - Ad
The Hedge Fund Summit is bringing top minds from crypto and traditional finance together. Discover new strategies, insights, and connections that could shape your portfolio's future.
Kevin O'Leary Says Trump's $100,000 H1B Visa Will Push Innovation Abroad, Points Out Apple, Google Started In A Garage Once
Investor Kevin O'Leary warned that Trump's new $100,000 H-1B visa fee could drive top talent overseas, threatening U.S. innovation and startups.
Cracker Barrel, D-Wave Quantum, IonQ, Krispy Kreme And Broadcom: Why These 5 Stocks Are On Investors' Radars Today
On Wednesday, U.S. stocks closed mixed as the Dow Jones Industrial Average advanced 0.6% to 46,018.32.
Nvidia Is About to Shock the World: October 23rd - Ad
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: October 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.
Labor Dispute Eases As UAW, GE Aerospace Agree On Tentative Pact
UAW members at GE Aerospace plants in Ohio and Kentucky reached a tentative deal, with a ratification vote set for Sept. 19.
Neighbors help neighbors with resources like clothing swaps, community fridges
When Cassie Ridgway held her first clothing swap in Portland, Oregon, 14 years ago, she had a few goals: keep , help people find free fashion treasures and .
New Biotech Offering Targets $426B Rare Disease Market - Ad
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
US To Set $5 Billion Critical Minerals Fund
US to launch $5 billion fund for critical minerals, in partnership with Orion Resource Partners and other investors. Aimed at reducing reliance on Chinese supply chains and securing long-term resources.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.